Predictive Oncology Statistics Share Statistics Predictive Oncology has 726.08K
shares outstanding. The number of shares has increased by 65.02%
in one year.
Shares Outstanding 726.08K Shares Change (YoY) 65.02% Shares Change (QoQ) 23.18% Owned by Institutions (%) 2% Shares Floating 718.97K Failed to Deliver (FTD) Shares 307 FTD / Avg. Volume 0.37%
Short Selling Information The latest short interest is 98.86K, so 12.97% of the outstanding
shares have been sold short.
Short Interest 98.86K Short % of Shares Out 12.97% Short % of Float 13.1% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -5.5 and the forward
PE ratio is 11.23.
Predictive Oncology's PEG ratio is
0.15.
PE Ratio -5.5 Forward PE 11.23 PS Ratio 41.31 Forward PS 0.6 PB Ratio -331.08 P/FCF Ratio -6.11 PEG Ratio 0.15
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Predictive Oncology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.62,
with a Debt / Equity ratio of -10.52.
Current Ratio 0.62 Quick Ratio 0.51 Debt / Equity -10.52 Debt / EBITDA -0.21 Debt / FCF -0.19 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $70.6K Profits Per Employee $-530.49K Employee Count 23 Asset Turnover 0.33 Inventory Turnover 2.14
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 64.61% in the
last 52 weeks. The beta is 1.32, so Predictive Oncology's
price volatility has been higher than the market average.
Beta 1.32 52-Week Price Change 64.61% 50-Day Moving Average 13.9 200-Day Moving Average 16.02 Relative Strength Index (RSI) 46.58 Average Volume (20 Days) 83,320
Income Statement In the last 12 months, Predictive Oncology had revenue of 1.62M
and earned -12.2M
in profits. Earnings per share was -2.24.
Revenue 1.62M Gross Profit 797.68K Operating Income -10.94M Net Income -12.2M EBITDA -10.24M EBIT -10.94M Earnings Per Share (EPS) -2.24
Full Income Statement Balance Sheet The company has 734.67K in cash and 2.13M in
debt, giving a net cash position of -1.4M.
Cash & Cash Equivalents 734.67K Total Debt 2.13M Net Cash -1.4M Retained Earnings -180.43M Total Assets 3.44M Working Capital -2.62M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.97M
and capital expenditures -9.51K, giving a free cash flow of -10.98M.
Operating Cash Flow -10.97M Capital Expenditures -9.51K Free Cash Flow -10.98M FCF Per Share -2.01
Full Cash Flow Statement Margins Gross margin is 49.12%, with operating and profit margins of -673.69% and -751.39%.
Gross Margin 49.12% Operating Margin -673.69% Pretax Margin -668.81% Profit Margin -751.39% EBITDA Margin -630.85% EBIT Margin -673.69% FCF Margin -676.44%
Dividends & Yields POAI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for POAI.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Sep 30, 2025. It was a
backward
split with a ratio of 1:15.
Last Split Date Sep 30, 2025 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -83.3 Piotroski F-Score 2
